Oruka Therapeutics stock hits 52-week high at 109.56 USD
AI Summary
Oruka Therapeutics stock reached a 52-week high, trading at $109.56 USD, indicating positive investor sentiment and strong performance in the biotech sector. This milestone highlights market confidence in the company’s prospects.